AHK-Cu (50mg)

Research Overview

A copper-binding tripeptide closely related to GHK-Cu but with stronger selectivity for hair-follicle biology. Widely studied in cosmetic dermatology for promoting VEGF expression in dermal papilla cells, elongating the anagen phase of the hair cycle and improving follicular perfusion.

Origin: Synthetic copper-binding tripeptide analogue of the naturally occurring GHK motif

Mechanism of Action

• Copper(II) delivery to dermal tissue

• VEGF upregulation in dermal papilla cells

• Extension of the anagen (growth) phase

• Dermal microvascular angiogenesis

• Keratinocyte proliferation

Primary Research Areas

• Androgenic alopecia models

• Hair follicle cycling

• Dermal angiogenesis

• Scalp cosmetic research

Key Published Findings

• Induced VEGF expression and elongated anagen phase in dermal papilla cells (Pyo et al., 2007)

• Enhanced follicular cycling in isolated hair follicle organ culture

• Synergistic follicular effects when combined with GHK-Cu and biotinoyl tripeptide-1

Research Protocol

Commonly studied routes: Topical, Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.

Storage

-20°C lyophilized; protect from light

Important Notice

AHK-Cu (50mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.